AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |
| Knott David M Jr | 221,850 | $2,285 | 0.87% |
| SCHULHOFF & CO INC | 96,000 | $988,800 | 0.50% |
| Lion Point Capital, LP | 80,000 | $824,000 | 0.37% |
| Edge Wealth Management LLC | 150,000 | $1,545,000 | 0.36% |
| Polar Capital Holdings Plc | 4,512,964 | $46,483,529 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 1,448,772 | $14,922,352 | 0.29% |
| ADVISORY RESEARCH INC | 201,109 | $2,071,423 | 0.29% |
| Woodline Partners LP | 1,902,843 | $19,599,283 | 0.23% |
| KENNEDY CAPITAL MANAGEMENT LLC | 715,424 | $7,368,867 | 0.18% |
| Modera Wealth Management, LLC | 594,000 | $6,118,200 | 0.12% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.